Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, UMDNJ-New Jersey Medical School, Department of Medicine, New Jersey (Dr Scollan-Koliopoulos, Dr Bleich)
UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey (Mr Rapp)
Diabetes Educ. 2012 Jul-Aug;38(4):488-98. doi: 10.1177/0145721712445213. Epub 2012 May 18.
The purpose of this study was to estimate the benefit of using a cultural characteristics scale to help diabetes educators understand how African Americans cope with diabetes. Illness representations are influenced by culture. Race and ethnicity as a proxy for culture provides an incomplete understanding of the mechanism by which cultural values influence representations of diabetes.
A descriptive correlational design was employed by recruiting hospitalized adults with type 2 diabetes at 3 metropolitan northeast coast sites. The TRIOS Afrocentric cultural characteristics measure and the Illness perception Questionnaire were administered by paper-and-pencil to a diverse sample. Black race and African American ethnicity was used as a proxy for culture and compared to levels of agreement on an Afrocentric cultural scale to determine the relative ability to explain variance in illness representations of diabetes.
The TRIOS measure adapted to diabetes care explained variance in illness representations of diabetes, while African American ethnicity/black race was not able to explain variance in illness representations. Clinicians would benefit from considering the degree to which a patient identifies with particular cultural characteristics when tailoring interventions to manipulate illness representations that are not concordant with biomedical representations.
本研究旨在评估使用文化特征量表来帮助糖尿病教育者了解非裔美国人如何应对糖尿病的益处。疾病认知受文化影响。种族和民族作为文化的代表并不能完全理解文化价值观影响糖尿病认知的机制。
采用描述性相关设计,在东北部沿海的 3 个大都市地点招募住院的 2 型糖尿病成年患者。通过纸质问卷向不同种族的患者发放 TRIOS 非裔美国人文化特征量表和疾病感知问卷。将黑种人种族和非裔美国人种族作为文化的代表,并与非裔美国人文化量表的一致性水平进行比较,以确定解释糖尿病疾病认知差异的相对能力。
适应于糖尿病护理的 TRIOS 量表解释了糖尿病疾病认知的差异,而非裔美国人种族/黑种人种族并不能解释疾病认知的差异。当临床医生根据患者的特定文化特征来调整干预措施以改变与生物医学认知不一致的疾病认知时,患者将从中受益。